Gelest Inc., manufacturer, and supplier of silicones, organosilanes, metal-organics and specialty monomers, appoints Dr. Barry Arkles to chief executive officer, effective immediately. Arkles is also the chairman of the board of Gelest, the company he co-founded in 1991. On October 1, 2020, Gelest was acquired by Mitsubishi Chemical America, Inc., the U.S. subsidiary of Mitsubishi Chemical Corporation. Arkles’ appointment follows the resignation of Ken Gayer as CEO of Gelest.
“Dr. Arkles’ comprehensive knowledge of the business and technology of Gelest provides excellent continuity as members of the talented leadership team join to support the continued growth of the company in the key markets served: medical device, semiconductor, personal care, pharmaceutical and diagnostic science,” says Steve Yurich, president of MCA.
For more information, visit www.gelest.com